Finally, we conducted studies to determine whether expression of CXCR2 improved the anti-tumor activity of canine B7-H3 CAR T cells, using a mouse xenograft model of NSG mice implanted with canine OS cells. The gene discussed is CXCR2; the disease is neoplasm.